Aviance Capital Management’s OPTIMER PHARMACEUTICALS, INC. COM STK OPTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2013
Q4
Sell
-184
Closed -$2K 509
2013
Q3
$2K Buy
+184
New +$2.44K ﹤0.01% 420

Aviance Capital Management's OPTR Position: Q4 2013 in Review

Aviance Capital Management sold out of OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) in Q4 2013, closing a stake of 184 shares — an estimated $2K sold.

Aviance Capital Management first reported a position in OPTR in Q3 2013 and held it in 1 quarter. The position peaked at $2K in Q3 2013. 0 funds tracked by Wall St. Rank hold OPTR as of Q4 2013.

  • Aviance Capital Management reported no remaining OPTIMER PHARMACEUTICALS, INC. COM STK position as of Q4 2013 after selling out during the quarter.
  • Aviance Capital Management sold 184 OPTIMER PHARMACEUTICALS, INC. COM STK shares in Q4 2013, an estimated $2K.
  • Aviance Capital Management first reported a position in OPTIMER PHARMACEUTICALS, INC. COM STK in Q3 2013 and held it in 1 quarter.
  • Aviance Capital Management's OPTIMER PHARMACEUTICALS, INC. COM STK position peaked at $2K in Q3 2013.
  • 0 funds tracked by Wall St. Rank held OPTIMER PHARMACEUTICALS, INC. COM STK as of Q4 2013.

Based on Aviance Capital Management's 13F filing for Q4 2013, filed 12 Feb 2014.